As of today, our real-world data repository at Glooko represents over five billion data points with 3.4 million users globally in over 7,500 clinics across 29 countries in 21 languages. The robust data points we gather that’s constantly growing each day include continuous blood glucose readings, insulin, exercise, food, medications, blood pressure, weight and patient demographics.
Our real-world data is currently being used in retrospective clinical research trials, which could potentially lead to breakthrough digital therapeutic solutions that better manage patients’ health.
And this month, Glooko joined the AWS Marketplace, Amazon’s digital catalog of commercial data products from category-leading data providers that enables individuals and companies to find, subscribe and use third-party data in the cloud.
Our leading digital health company’s de-identified patient data is now available to be applied across multiple use cases, including clinical trial design and recruitment, pre- and post-efficacy analysis of pharmaceutical interventions, population health studies and health economics and outcomes research (HEOR). Clinical researchers, data scientists and others in the life sciences space will be able to benefit greatly if they’re interested in:
-
Blood glucose statistics
-
Insulin statistics
-
Diabetes device utilization
-
Blood glucose and insulin-related statistics
-
Blood glucose readings
-
Demographics information
-
Biometrics information
-
Lifestyle data
These data points are collected by Glooko when our platform users upload and share their data in-clinic or through remote data collection tools, like the Glooko Research Mobile App, available on the App Store and Google Play Store, and the Glooko Research Uploader.
“There are so many beneficial uses of this data from patients with diabetes and related chronic conditions,” said Kevin Dougherty, vice president, life sciences at Glooko. “AWS Marketplace allows clinical researchers to easily access and utilize our existing datasets in their retrospective clinical trials to help better inform decision-making around device selection, post-marketing and HEOR.”
Some of the additional use cases for Glooko’s data include understanding how devices and wearables perform in a variety of typical practice settings and populations, as well as demonstrating the value of medicine and devices through evidence-based health economic evaluation and real-world outcomes for pricing, reimbursement and overall cost of a disease.
To access Glooko’s de-identified patient data, visit our AWS Marketplace listing and subscribe or email our team.
